CD40LG and COVID-19: In this study we studied the characteristics and kinetics of SARS-CoV-2 specific antibody response (nAbs, IgG, and IgM) in a series of serum samples collected from a total of 87 confirmed COVID-19 hospitalized patients over a period of 70 days post-symptoms onset.